Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole.
Martin JuhásAndrea BachtíkováDaria Elżbieta NawrotPaulína Dudášová-HatokováVinod Sukanth Kumar PallabothulaAdéla DiepoltováOndřej JanďourekPavel BártaKlára KonečnáPavla PaterováVít ŠestákFotios TsopelasPublished in: Pharmaceuticals (Basel, Switzerland) (2022)
Antimicrobial drug resistance is currently one of the most critical health issues. Pathogens resistant to last-resort antibiotics are increasing, and very few effective antibacterial agents have been introduced in recent years. The promising drug candidates are often discontinued in the primary stages of the drug discovery pipeline due to their unspecific reactivity (PAINS), toxicity, insufficient stability, or low water solubility. In this work, we investigated a series of substituted N -oxazolyl- and N -thiazolylcarboxamides of various pyridinecarboxylic acids. Final compounds were tested against several microbial species. In general, oxazole-containing compounds showed high activity against mycobacteria, especially Mycobacterium tuberculosis (best MIC H37Ra = 3.13 µg/mL), including the multidrug-resistant strains. Promising activities against various bacterial and fungal strains were also observed. None of the compounds was significantly cytotoxic against the HepG2 cell line. Experimental measurement of lipophilicity parameter log k' w and water solubility (log S ) confirmed significantly (typically two orders in logarithmic scale) increased hydrophilicity/water solubility of oxazole derivatives in comparison with their thiazole isosteres. Mycobacterial β-ketoacyl-acyl carrier protein synthase III (FabH) was suggested as a probable target by molecular docking and molecular dynamics simulations.
Keyphrases
- molecular docking
- molecular dynamics simulations
- mycobacterium tuberculosis
- drug discovery
- multidrug resistant
- escherichia coli
- gram negative
- public health
- staphylococcus aureus
- rheumatoid arthritis
- emergency department
- drug resistant
- acinetobacter baumannii
- pulmonary tuberculosis
- health information
- pseudomonas aeruginosa
- binding protein
- high resolution
- structure activity relationship
- drug induced
- cystic fibrosis
- idiopathic pulmonary fibrosis
- oxide nanoparticles